Drug Type Small molecule drug |
Synonyms BMY-25801 |
Target |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H26ClN3O3 |
InChIKeyZYOJXUNLLOBURP-UHFFFAOYSA-N |
CAS Registry102670-46-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Batanopride | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-induced nausea and vomiting | Phase 1 | US | 01 Sep 1990 | |
Drug-induced nausea and vomiting | Preclinical | US | 01 Mar 1988 |